Experimental and clinical observations on frostbite.

Area of Science:

• Biomedical Science
• Dermatology
• Pharmacology

Background:

• Frostbite causes progressive dermal ischemia, a condition exacerbated by thromboxane.
• Understanding the role of thromboxane in frostbite injury is crucial for developing effective treatments.

Purpose of the Study:

• To investigate the efficacy of various therapeutic agents in mitigating frostbite-induced ischemia.
• To compare a modified frostbite protocol with other clinical treatment modalities.

Main Methods:

• Experimental frostbite induced in rabbit ears to evaluate therapeutic agents like antiprostanoids, methylprednisolone, aspirin, Aloe vera, and methimazole.
• Clinical data analysis of 154 frostbite patients, comparing outcomes between a specific protocol and other treatments.

Main Results:

• In rabbit models, methimazole (34.3%) and Aloe vera (28.2%) showed higher tissue survival rates compared to aspirin (22.5%) and methylprednisolone (17.5%).
• The frostbite protocol group demonstrated significantly better healing outcomes (67.9% without tissue loss) compared to other treatment modalities (32.7% without tissue loss).
• The protocol group also had a lower amputation rate (7%) versus the non-protocol group (32.7%).

Conclusions:

• Therapeutic inhibition of the arachidonic acid cascade can decrease the morbidity associated with progressive dermal ischemia in frostbite.
• The study highlights the potential of agents like methimazole and Aloe vera in frostbite treatment.
• A modified frostbite protocol shows superior clinical efficacy in preventing tissue loss and amputation.